NCT06530030 - Goal Attainment and Physical Activity in People With Hemophilia A | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 26, 2024

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions

Hemophilia A

Interventions

DRUG

efanesoctocog alfa

All treatment decisions must be made independent of study participation and study-related visits/assessments are not intended to inform treatment decisions. No study medication is provided as part of study participation.

Trial Locations (1)

61614

RECRUITING

Bleeding and Clotting Disorders Institute, Peoria